Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early stage breast cancer: A prospective trial

被引:1
|
作者
Haddad, Tufia C.
Suman, Vera
Giridhar, Karthik V.
Moreno-Aspitia, Alvaro
Northfelt, Donald
Ernst, Brenda
Sideras, Kostandinos
O'Sullivan, Ciara C.
Singh, Ravinder
Desta, Zeruesenay
Taraba, Jodi
Goodnature, Barbara
Goetz, Matthew P.
Wang, Liewei
Ingle, James N.
机构
关键词
D O I
10.1158/1538-7445.SABCS22-OT1-04-02
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OT1-04-02
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial
    Haddad, Tufia C.
    Suman, Vera J.
    Giridhar, Karthik V.
    Sideras, Kostandinos
    Northfelt, Donald W.
    Ernst, Brenda J.
    O'Sullivan, Ciara C.
    Singh, Ravinder J.
    Desta, Zeruesenay
    Peethambaram, Prema P.
    Hobday, Timothy J.
    Chumsri, Saranya
    Leon-Ferre, Roberto A.
    Ruddy, Kathryn J.
    Yadav, Siddhartha
    Taraba, Jodi L.
    Goodnature, Barbara
    Goetz, Matthew P.
    Wang, Liewei
    Ingle, James N.
    CLINICAL CANCER RESEARCH, 2024, 30 (15) : 3147 - 3156
  • [2] SYMPTOM TRAJECTORIES IN POSTMENOPAUSAL WOMEN PRESCRIBED ANASTROZOLE FOR EARLY STAGE BREAST CANCER
    McCall, Maura
    Sereika, Susan
    Rosenzweig, Peg
    Snader, Stephanie
    Conley, Yvette
    Bender, Cathy
    ONCOLOGY NURSING FORUM, 2021, 48 (02) : 41 - 42
  • [3] Anastrozole - A review of its use in postmenopausal women with early-stage breast cancer
    Sanford, Mark
    Plosker, Greg L.
    DRUGS, 2008, 68 (09) : 1319 - 1340
  • [4] Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α
    Ingle, James N.
    Cairns, Junmei
    Suman, Vera J.
    Shepherd, Lois E.
    Fasching, Peter A.
    Hoskin, Tanya L.
    Singh, Ravinder J.
    Desta, Zeruesenay
    Kalari, Krishna R.
    Ellis, Matthew J.
    Goss, Paul E.
    Chen, Bingshu E.
    Volz, Bernhard
    Barman, Poulami
    Carlson, Erin E.
    Haddad, Tufia
    Goetz, Matthew P.
    Goodnature, Barbara
    Cuellar, Matthew E.
    Walters, Michael A.
    Correia, Cristina
    Kaufmann, Scott H.
    Weinshilboum, Richard M.
    Wang, Liewei
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 2986 - 2996
  • [5] Phase I dose escalation trial using single fraction Stereotactic PBI for early stage breast cancer
    Rahimi, A.
    Kim, N.
    Spangler, A.
    Leitch, M.
    Alluri, P.
    Gu, X.
    Ahn, C.
    Goudreau, S.
    Seiler, S.
    Farr, D.
    Wooldridge, R.
    Haley, B.
    Bahrami, S.
    Chen, D.
    Rao, R.
    Timmerman, R.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S706 - S706
  • [6] Trajectories of neuropsychological symptom burden in postmenopausal women prescribed anastrozole for early-stage breast cancer
    Maura K. McCall
    Susan M. Sereika
    Stephanie Snader
    Alexa Lavanchy
    Margaret Q. Rosenzweig
    Yvette P. Conley
    Jan H. Beumer
    Catherine M. Bender
    Supportive Care in Cancer, 2022, 30 : 9329 - 9340
  • [7] Trajectories of neuropsychological symptom burden in postmenopausal women prescribed anastrozole for early-stage breast cancer
    McCall, Maura K.
    Sereika, Susan M.
    Snader, Stephanie
    Lavanchy, Alexa
    Rosenzweig, Margaret Q.
    Conley, Yvette P.
    Beumer, Jan H.
    Bender, Catherine M.
    SUPPORTIVE CARE IN CANCER, 2022, 30 (11) : 9329 - 9340
  • [8] Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole
    Ingle, James N.
    Kalari, Krishna R.
    Buzdar, Aman U.
    Robson, Mark E.
    Goetz, Matthew P.
    Desta, Zeruesenay
    Barman, Poulami
    Dudenkov, Tanda T.
    Northfelt, Donald W.
    Perez, Edith A.
    Flockhart, David A.
    Williard, Clark V.
    Wang, Liewei
    Weinshilboum, Richard M.
    STEROIDS, 2015, 99 : 32 - 38
  • [9] Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer
    Kyvernitakis, I.
    Albert, U-S.
    Kalder, M.
    Winarno, A-S.
    Hars, O.
    Hadji, P.
    CLIMACTERIC, 2015, 18 (01) : 63 - 68
  • [10] Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer
    Ingle, James N.
    Kalari, Krishna R.
    Barman, Poulami
    Shepherd, Lois E.
    Ellis, Matthew J.
    Goss, Paul E.
    Buzdar, Aman U.
    Robson, Mark E.
    Cairns, Junmei
    Carlson, Erin E.
    Eyman Casey, Abraham
    Hoskin, Tanya L.
    Goodnature, Barbara A.
    Haddad, Tufia C.
    Goetz, Matthew P.
    Weinshilboum, Richard M.
    Wang, Liewei
    PHARMACOGENETICS AND GENOMICS, 2021, 31 (01): : 1 - 9